The city of Boston will soon be flooded with runners who have been diligently training for the 2018 Boston Marathon. Most runners will be feeling excited that the day has finally arrived – but there will also be some who are dreading it, as they are dealing with the common running injury Achilles tendonitis.
February is American Heart Month
Most people don’t know that prostate cancer is the second most common cancer among American men, affecting roughly 1 in every 7. Early detection is the key to treating prostate cancer – so here is what you should know…..
prostate cancer awareness,
multiparametric prostate mri,
mens health awareness
Emmy-award-winning actress Julia Louis-Dreyfus was recently diagnosed with breast cancer and announced it using a startling statistic: “One in eight women get breast cancer. Today, I’m the one.”
- Its more common than breast cancer.
For men at average risk, about one man in seven will be diagnosed with prostate cancer in his lifetime. According to the National Cancer Institute, it’s the second most common cancer for men, representing 7 percent of cancer diagnoses each year, and 4.4 percent of cancer deaths.
- Early detection greatly increases survival rates.
Most prostate cancers grow slowly and if the cancer is caught at its earliest stages, the disease is extremely treatable.
- Some men have no symptoms.
Early detection of prostate cancer is important, but it can be difficult because oftentimes men don’t experience any symptoms in the early stages. Assessing risk factors such as age, family history and race as well as discussing prostate cancer screening with your doctor will help you to identify your risk of developing prostate cancer.
- Current screening tools tell only part of the story.
Screening often begins with a blood test to measure the level of prostate specific antigen (PSA). If elevated, it might indicate cancer and doctors are tasked with discovering more. After an elevated PSA, the next step is a needle biopsy, where a doctor takes multiple samples from the prostate and has them tested for cancer. While the PSA test is a relatively simple and inexpensive blood test, the biopsy is very invasive, done by inserting a thin needle through the rectum, and costs an average of $2,000. The PSA test combined with the random biopsy may miss a potential cancer or indicate the need for more testing. Often, the result is that the patient needs to be continuously monitored since the tests are not able to identify if a cancer is present or if it is aggressive.
- MRI has been called the “mammogram” for prostate cancer.
Many specialists are turning to advanced imaging as a way to reduce unnecessary prostate biopsies following an elevated PSA. Multiparametric MRI (mpMRI) can reveal the size and density of a prostate cancer, and how well-connected it is to the blood supply. While this newer test is not as common as biopsies, when combined with ultrasound, the hope is that it will be more precise and reduce the number of invasive biopsies needed. The benefits of mpMRI from a patient comfort standpoint are also positive – it is a non-invasive test that is extremely precise with no radiation or side effects.
prostate cancer awareness,
shields prostate mri
On a high-deductible health plan this year? You are not alone! More and more employers are implementing these plans that put more of the responsibility to pay out-of-pocket for certain health care procedures onto the patient. As a health care provider, Shields is seeing a rise in inquiries around price for an MRI scan, which have a reputation for being a high-cost imaging procedure.
An average of one in ten people need an MRI each year and if you are one of them, chances are that you’re a tad nervous. Hopefully knowing these 7 things about MRIs beforehand will help you have an easier and pleasant experience.